Biotech Analyst Brayer, along with Key Opinion Leader Dr. de Jesus Perez of Stanford University and Dr. Zusman of Mass General Hospital discuss PAH treatments in development ahead of Gossamer’s upcoming Phase 2 TORREY Readout on an Analyst/Industry conference call to be held on November 18 at 12 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GOSS:
- Goldman Sachs Says These 2 Buy-Rated Stocks Have at Least 60% Upside Potential
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Gossamer Bio initiated with a Buy at Goldman Sachs
- Merck data ‘positive read through’ to Gossamer, says Piper Sandler
- Gossamer Bio initiated with Neutral into ‘binary event’ at JPMorgan